endohpb brochure final

8/6/2019 EndoHPB Brochure Final

1/3

For the Palliation of Biliaryand Pancreatic Tumours

HabibTMEndoHPB

Endoscopy


2/3

With the ERCP approach a guidewire

is inserted in the CBD showing

complete biliary obstruction.

EndoHPB inserted via the ERCP

approach over the guidewire.

Following removal of the EndoHPB

catheter contrast is seen in the lower

end of the CBD.

Metal stent insertion following RF

ablation of an inoperable tumour in

the head of pancreas

The HabibTM EndoHPB

The HabibTM EndoHPB was cleared by

FDA 510 (k) to be used to assist in the

coagulation of tissue during Endoscopic

surgical procedures in the Gastro-intestinal

Tract.

This novel endoscopic bipolar radiofrequency

(RF) probe has been used for the

palliation of malignant biliary obstructions

from cholangiocarcinoma or pancreatic

adenocarcinoma.

The RF catheter has been used by

endoscopists for tumours in the bile duct

and head of pancreas for partial destruction

of the tumour prior to stent insertion and for

clearance of obstructed metal stents.

The HabibTM EndoHPB is an 8Fr (2.6mm)

catheter which has a useable length of 180cm

and two stainless steel ring electrodes at the

distal tip. It is compatible with endoscopes

that have a working channel 3.2mm or

greater. The catheter is introduced over a

0.035 guidewire into the common bile duct

(CBD) via the Ampulla of Vater. The catheter

is manipulated into the CBD where it is used

to heat and ablate tissue. The electrodes are

designed to operate at an efcient energy

level and are activated at 10 Watts for only 90

seconds before the stent is inserted.

A recent clinical trial reported in

Gastrointestinal Endoscopy Journal

of 22 patients (16 pancreatic, 6

cholangiocarcinoma) who were treated with

the EndoHPB catheter between January

2009 and April 2010. Deployment of the

catheter was successful in 21 patients. Self

Expanding Metal Stent (SEMS) placement

was achieved in all cases of successful

RFA catheter deployment. One patient

failed to demonstrate successful biliary

decompression after SEMS placement

and died within 90 days. All other patients

maintained stent patency at 30 days (Steel et

al GIE 2011;73:149-153).

The HabibTM EndoHPB can be used with

the following radiofrequency generators:

Radionics Cosman Coagulator CC-1, the

RITA Medical Systems 1500, the RITA

Medical Systems 1500X, the Conmed 5000,

the ERBE VIO 200D and the ERBE VIO

300D.

Please contact us at [email protected] or

visit www.emcision.com for more information

ENDOSCOPIC INSERTION ANDACTIVATION OF THE HABIBTM

ENDOHPB


3/3

IMPORTANT

Prior to use, refer to the Instructions for Use supplied with the

device for indications, contraindications, adverse effects,

suggested procedure, warnings, and precautions.

A 90cm length catheter specically for percutaneous

use is available to order (ordering information HabibTM

Percutaneous EndoHPB - Product number 6700).

PUBLICATION

Steel AW., et al. Endoscopically applied

radiofrequency ablation appears to be safe in

the treatment of malignant biliary obstruction.

Gastrointestinal Endoscopy 2011;73(1):149-

153.

HabibTM Endoblate

Ablation of tumours in hollow

organs

HabibTM VesCoag

For precise vascular occlusion

HabibTM Hexablate

Ablation of inoperable solid

tumours

Please contact us at [email protected] or

visit www.emcision.com for more information

OTHER EMCISIONPRODUCTS

6800 8Fr (2.6mm),

UseableLength 180cm

Cleared

Class II

Cleared

Class IIb

3 years Endoscope

3.2mm channel0.035 guidewire

HabibTM

EndoHPB

P/N Specications FDA Status

(class)

CE Status

(class)

Shelf life Required

accessories

EMD01 Rev 5

endohpb brochure final

Documents